Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 6,800.00
-500.00 (-6.85%)
At close: Feb 6, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 156.87 billion as of February 6, 2026. Its market cap has increased by 45.77% in one year.
Market Cap
156.87B
Enterprise Value
139.78B
Revenue
25.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,800.00
Market Cap Chart
Since November 22, 2018, Cytogen's market cap has increased from 87.89B to 156.87B, an increase of 78.49%. That is a compound annual growth rate of 8.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 156.87B | -24.36% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 418.93B |
| Dx & Vx | 406.51B |
| GENINUS | 104.56B |
| Green Cross Medical Science | 83.27B |
| HLB Panagene | 74.66B |
| Protia | 67.35B |
| Seoulin Bioscience | 54.73B |
| GeneMatrix | 50.27B |